Singapore markets open in 2 hours 24 minutes
Straits Times Index
3,293.13 +20.41 (+0.62%) S&P 500
5,071.63 +1.08 (+0.02%) Dow
38,460.92 -42.77 (-0.11%) Nasdaq
15,712.75 +16.11 (+0.10%) Bitcoin USD
64,173.00 -2,267.84 (-3.41%) CMC Crypto 200
1,386.51 -37.59 (-2.64%)
Atossa Therapeutics, Inc. (ATOS)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 185.45M |
| Enterprise value | 96.99M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 2.04 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -3.09 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.24 |
| 52-week change 3 | 148.33% |
| S&P500 52-week change 3 | 25.01% |
| 52-week high 3 | 2.3100 |
| 52-week low 3 | 0.5900 |
| 50-day moving average 3 | 1.3944 |
| 200-day moving average 3 | 0.9776 |
Share statistics
| Avg vol (3-month) 3 | 1.65M |
| Avg vol (10-day) 3 | 1.78M |
| Shares outstanding 5 | 125.3M |
| Implied shares outstanding 6 | 125.3M |
| Float 8 | 117.48M |
| % held by insiders 1 | 0.06% |
| % held by institutions 1 | 19.20% |
| Shares short (28 Mar 2024) 4 | 10.56M |
| Short ratio (28 Mar 2024) 4 | 5.37 |
| Short % of float (28 Mar 2024) 4 | 8.43% |
| Short % of shares outstanding (28 Mar 2024) 4 | 8.43% |
| Shares short (prior month 29 Feb 2024) 4 | 7.15M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 20 Apr 2018 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:12 |
| Last split date 3 | 20 Apr 2018 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -17.84% |
| Return on equity (ttm) | -28.80% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -31.35M |
| Net income avi to common (ttm) | -30.09M |
| Diluted EPS (ttm) | -0.2400 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 88.46M |
| Total cash per share (mrq) | 0.71 |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 17.61 |
| Book value per share (mrq) | 0.73 |
Cash flow statement
| Operating cash flow (ttm) | -20.94M |
| Levered free cash flow (ttm) | -11.76M |
© 2024 Yahoo. All rights reserved.